PATTERN OF TREATMENT APPROACHES FOR PREECLAMPSIA DURING PREGNANCY

Abstract

Preeclampsia is a hypertensive disorder that is now predictable during its advanced stage of severity and that may cause risk to the life of the mother and fetus. Preeclampsia is a condition categorized by increase in systolic blood pressure from ≥140 mmHg and diastolic blood pressure from ≥90 mmHg on checking at least two times within 4 hours after 20 weeks of pregnancy for those women previously having normal blood pressure and other parameters like with or without proteinuria ≥0.3 gm test in urine within 24 hour or the ratio of protein /creatinine more than 0.3 mg/dl and thrombocytopenia, changes in renal functioning, hepatic dysfunction. In developing countries, preeclampsia is defined as a chief cause of maternal and perinatal mortality rates. Preeclampsia may be responsible for causing premature cardiovascular diseases, such as chronic hypertension, ischemic heart disease, and stroke to the mother or pregnant women, whereas children born from women having preeclampsia are at increased risk of such diseases like stroke, congestive heart failure, and metabolic disorder in adult life. For the management of preeclampsia, major factors that are necessary to maintain is screening of women at high risk and prevention from reoccurrence. Three groups of current preeclampsia management are (Preventive measures of preeclampsia, Primary examination, and management).